"READ-GENE" SPÓŁKA AKCYJNA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
"READ-GENE" SPÓŁKA AKCYJNA
Contacts
Registered address
Copy
Website
WWW.READ-GENE.COM
B
HighReliability
B - HighIncorporation date
27/09/2005Share capital
589,500.50 PLNPrimary activity
Research and experimental development on biotechnology (72.11.Z - PKD 2007)Representatives
0Representatives rights
DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI UPOWAŻNIENI SĄ: W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO - PREZES ZARZĄDU LUB KAŻDY Z PROKURENTÓW SAMODZIELNIE, A W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO - PREZES ZARZĄDU SAMODZIELNIE, JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-1,243,293Net Profit (zł)
-1,243,293Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 4,280,739 |
| 70,409 |
| 222,853 |
| 1.73 |
| 23.22 |
| 5.21 |
| 4,347,044 |
| 333,793 |
| 7,056,656 |
| 6,053,793 |
| 2023 |
|---|
| 4,285,170 |
| -1,896,719 |
| -1,594,583 |
| 1.43 |
| 12.80 |
| -37.21 |
| 2,752,461 |
| 520,944 |
| 7,516,828 |
| 5,780,725 |
| 2024 |
|---|
| 6,216,247 |
| -728,503 |
| -1,243,293 |
| 0.93 |
| 7.74 |
| -20.00 |
| 1,509,169 |
| 861,719 |
| 7,908,069 |
| 5,682,902 |
| 2024 |
|---|
| 6,216,247 |
| -728,503 |
| -1,243,293 |
| 0.93 |
| 7.74 |
| -20.00 |
| 1,509,169 |
| 861,719 |
| 7,908,069 |
| 5,682,902 |
Turnover (zł)
2024
Turnover (zł)
6,216,247 zł
45 % *
Profit before tax (zł)
-728,503 zł62 % *
Net Profit (zł)
-1,243,293 zł22 % *
Working capital requirement (%)
0.93 
-34.97 % *
Liquidity ratio
7.74 
-39.53 % *
Net profitability (%)
-20.00 %46.25 % *
Equity (zł)
1,509,169 zł-45 % *
Current liabilities (zł)
861,719 zł65 % *
Non current liabilities (zł)
7,908,069 zł5 % *
Non-current Assets (zł)
5,682,902 zł
-2 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
"READ-GENE" SPÓŁKA AKCYJNA Documents
Date | Description |
|---|---|
14/07/2025 | OD 01.01.2024 DO 31.12.2024 |
07/07/2025 | OD 01.01.2024 DO 31.12.2024 |
19/07/2024 | OD 01.01.2023 DO 31.12.2023 |
24/07/2023 | OD 01.01.2022 DO 31.12.2022 |
13/07/2022 | OD 01.01.2021 DO 31.12.2021 |